National Institutes of Health (NIH)
Gain-of-Function Research on HPAI H5N1 Viruses: Welcome and Introductory Remarks
updated
Week of August 24, 2023:
1. An early-stage clinical trial indicated that deep brain stimulation (DBS) applied to the cerebellum may help recovery of upper limb function following stroke. This trial is the first-in-human test of post-stroke cerebellar DBS. bit.ly/3OE1MFj
2. Findings from a small study suggest severe COVID-19 may cause long-lasting alterations to the innate immune system, resulting in greater production of molecules called inflammatory cytokines. Researchers suspect one cytokine in particular, IL-6, is likely a major driver of long-term inflammation in people with severe COVID-19 and may provide new leads for therapies. bit.ly/3skIgGr
3. Use of marijuana and hallucinogens by adults 35 to 50 years old reached an all-time high in 2022, according to an annual survey of substance use behaviors and attitudes of adults 19 to 60 years old. Tracking this is important so that public health professionals and communities can be prepared to respond. bit.ly/3YHEl2C
4. Higher rates of new cases of dementia in a population over time — known as incident dementia — have been linked to long-term exposure to fine particulate matter air pollution. The findings suggest interventions that reduce air pollution may decrease the lifelong risk of developing dementia. bit.ly/3QKPXzL
Week of August 7, 2023:
1. A zebrafish image created by NIH researchers has been included in the new U.S. Postal Service’s “Life Magnified” stamp series. The stamps are now available at your local USPS! bit.ly/3KBFvXu
2. Researchers identified a genetic variant found in many people who didn’t develop symptoms when they were infected by SARS-CoV-2. Understanding how this variant helped people fend off the virus could lead to better ways to protect against COVID-19. bit.ly/3DTaomI
3. A study found that pregnant people who received COVID-19 vaccines generated antibodies against specific types of SARS-CoV-2 that crossed the placenta and were found in cord blood. The antibodies offered some protection for newborns against these variants immediately after birth—a critical time when they are vulnerable to severe COVID-19 disease but are too young to be vaccinated. bit.ly/45b0fhi
4. Hearing aids reduced the rate of cognitive decline in older adults at high risk of dementia by almost 50% over a three-year period. Treating hearing loss may be a safe way to lower the risk of dementia in vulnerable populations. bit.ly/3qtjFi5
Week of July 31, 2023
1. NIH launched Phase 2 clinical trials to test at least 4 potential Long COVID treatments through the RECOVER Initiative that will focus on viral persistence and cognitive dysfunction. go.nih.gov/6pgKeUC
2. RECOVER-VITAL will focus on SARS-CoV-2 persistence, which could occur if the virus stays in the body and causes the immune system to not function properly or damage to the organs. It will test a longer dose regimen of the antiviral PAXLOVID™ provided by Pfizer to see if it improves the symptoms of patients with Long COVID. go.nih.gov/6pgKeUC
3. RECOVER-NEURO will examine accessible interventions for cognitive dysfunction related to Long COVID, including brain fog, memory problems and difficulty with attention, thinking clearly and problem solving. go.nih.gov/6pgKeUC
4. Additional clinical trials to test at least seven more treatments are coming soon. The RECOVER Long COVID clinical trials are designed to accelerate the identification of safe and effective treatments for some of the most debilitating symptoms of Long COVID. They will evaluate drugs, biologics, medical devices and other therapies. go.nih.gov/6pgKeUC
To learn more about the RECOVER Long COVID clinical trials, visit:
trials.recovercovid.org
To learn more about the research being done in Haley's lab, visit ncats.nih.gov/preclinical/core/informatics
Interested in finding out for yourself what it's like to do research at NIH? Check out our training opportunities to learn about the IRP's programs for students, recent graduates, and postdoctoral fellows: irp.nih.gov/research-training/training-opportunities
The SciBites video shorts are produced by the @IRPatNIH. Check out their YouTube channel and visit their website at irp.nih.gov to learn more about the NIH IRP.
Week of July 24, 2023
1. A reduction in blood oxygen levels due to blocked airways has emerged as a leading factor explaining an increase in risk for cardiovascular disease in people with obstructive sleep apnea. The findings are from an NIH-funded study of more than 4,500 adults. go.nih.gov/4SXCJsy
2. People living with HIV are at high risk of developing cardiovascular disease. A new study found that statins, a class of cholesterol-lowering medications, may offset the high risk of cardiovascular disease in people living with HIV by more than a third, potentially preventing one in five major cardiovascular events or premature deaths in this population. go.nih.gov/ZJL6CaV
3. A device known as a cervical pessary, thought promising for reducing preterm birth risk due to a short cervix, appears no more effective than usual medical care and may increase risk of fetal or newborn death. go.nih.gov/AnVs28h
Week of July 17, 2023:
1. An NIH-funded study has created the most comprehensive atlas of the human kidney. Data from the new Kidney Tissue Atlas will allow the comparison of healthy kidney cells to those injured by kidney disease, helping investigators understand the factors that contribute to the progression of kidney disease and kidney failure or recovery from injury. go.nih.gov/uWyFbhS
2. Omega-3 fatty acids, which are abundant in fish and fish oil supplements, appear promising for maintaining lung health, according to new evidence from a large, multi-faceted study in healthy adults. This suggests nutrients with anti-inflammatory properties may help to maintain lung health. go.nih.gov/DN6ky4T
3. Women diagnosed and treated for breast cancer have increased biological aging compared to women who remain free of breast cancer, according to a new study. The association with faster biological aging was most pronounced for those who received radiation therapy for breast cancer, while surgery showed no association with biological aging, supporting efforts to minimize radiation exposures when possible and to find ways to mitigate adverse health effects. go.nih.gov/EBGRTRC
4. The National Institute of Allergy and Infectious Diseases has awarded funds for research to better understand Post-treatment Lyme Disease Syndrome (PTLDS), which is a collection of symptoms, such as pain, fatigue, and difficulty thinking or “brain fog,” which linger following standard treatment for Lyme disease. go.nih.gov/SYFiXF3
Week of July 10, 2023:
1. Two recent studies found factors on the male Y chromosome that lead to aggressive tumor growth. These results may help explain why some cancers have different prognoses in men and women and offer potential novel treatment strategies. go.nih.gov/MQ05tU1
2. More evidence supports that newborn screening for severe combined immunodeficiency (SCID), a rare disorder caused by mutations in genes involved in the development and function of immune cells, boosted survival of children with the disorder due to prompt treatment before life-threatening infections occurred. go.nih.gov/5DZA5Ff
3. The use of low-dose atropine eyedrops was found to be no more effective than placebo at slowing nearsightedness progression and elongation of the eye in children. These findings contradict results from recent trials which showed a benefit from using atropine eye drops. go.nih.gov/aISi7lA
Week of July 3, 2023
1. A new study suggests that cells preparing to divide can reverse this process and return to a resting state, challenging long-held beliefs about cell division. The finding could point toward more effective treatments to potentially prevent cancer relapse. go.nih.gov/tRsiiMn
2. New research finds that children with mitochondrial genetic conditions have a weaker antibody response to viral infections. While more studies are needed, researchers hope to use the study results to help guide future treatment for patients with mitochondrial disorders. go.nih.gov/B1yVjXp
3. The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because the investigational course of treatment was found to be safe but ineffective. NIH continues to prioritize research to advance TB treatment. go.nih.gov/WWf4DHa
Week of June 26, 2023:
1. New research finds that Hydractinia, a tiny sea creature that lives on the shells of hermit crabs, can regenerate its entire body from its mouth by activating stem cells through a molecular process associated with biological aging. The research demonstrates how healing and aging are intertwined. go.nih.gov/k5SWg7J
2. An NIH-funded study has discovered there are changes to the gut microbiome in people with Alzheimer's before any obvious symptoms arise. This raises the possibility that doctors could test a patient’s stool sample to determine early risk for Alzheimer’s dementia. go.nih.gov/5tevbYG
3. NIH has awarded $50 million to launch the Persistent Poverty Initiative, the first major program to address the structural and institutional factors of persistent poverty in the context of cancer. The awards will be spread over the next five years across five centers. go.nih.gov/0D3IHmy
To learn more about the research being done in Riley's lab, visit ccr.cancer.gov/staff-directory/nyall-r-london
Interested in finding out for yourself what it's like to do research at NIH? Check out our training opportunities to learn about the IRP's programs for students, recent graduates, and postdoctoral fellows: irp.nih.gov/research-training/training-opportunities
The SciBites video shorts are produced by the @IRPatNIH. Check out their YouTube channel and visit their website at irp.nih.gov to learn more about the NIH IRP.
Week of June 19, 2023
1. Myasthenia gravis is an autoimmune disorder that causes muscle weakness. A new clinical trial suggests the advanced blood cancer immunotherapy known as CAR-T could be adapted to treat myasthenia gravis, offering a longer-lasting reduction in symptoms than current treatments. go.nih.gov/BOblwxi
2. Screening newborns for a deadly immune disease called severe combined immunodeficiency (SCID) can significantly boost the five-year survival rate of affected children, according to an NIH-funded study. Researchers hope more countries will introduce population-wide newborn screening for SCID. go.nih.gov/n9aVyVA
3. New research from an NIH-funded clinical trial found that taking low doses of aspirin daily increased the risk of anemia in people aged 65 years and older by approximately 20%. Given these findings, care providers may want to consider periodic monitoring of red blood cells or hemoglobin. Anemia in older adults is associated with dementia, cognitive decline and depressive symptoms. go.nih.gov/W2yg0wE
4. Xylazine is the active ingredient in a veterinary tranquilizer often added to illicit opioids. A study in rats suggests that when used in combination with opioids, xylazine may damage the ability of the brain to get oxygen. The research helps deepen understanding of how xylazine impacts overdose risk. go.nih.gov/8hteeSU
5. Using 3-D models of ovarian cancer tumors, scientists found differences in gene activity based on the location of the cancer cell in the tumor. This approach could eventually lead to more precise therapies by providing insight into cancer progression and treatment response. go.nih.gov/dN22NUT
Week of June 12, 2023
1. Researchers have gained new insights into the cellular and molecular features of psoriasis, an inflammatory skin disease. The findings may help to understand how severe skin inflammation at one site can lead to problems in other sites of the body. go.nih.gov/6UqSrom
2. NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people as only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder. go.nih.gov/MysNfdx
3. Men were significantly more vulnerable than women to overdose deaths involving opioid and stimulant drugs in 2020-2021, according to a new study analyzing death records data from across the United States. The study found that men had a 2–3 times greater rate of overdose mortality from opioids (like fentanyl and heroin) and psychostimulants (like methamphetamine and cocaine). While it has been known that men use drugs at higher rates than women, the researchers found that this alone does not explain the gap in overdose deaths, noting that biological, behavioral, and social factors likely combined to increase the mortality risk for men. go.nih.gov/b1kS0uK
4. Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI). go.nih.gov/5fCRSno
Week of June 5, 2023:
1. An experimental HIV vaccine showed promise in a recent first-in-human study. Researchers used a customized nanoparticle to learn more about guiding the immune system to mount a desired robust response, the type needed for an effective HIV vaccine. bit.ly/43pcu8Q
2. Researchers have identified a second brain receptor abnormality in sudden infant death syndrome (SIDS) cases. The findings may inform development of a test to identify infants most at risk for SIDS, as well as ways to prevent SIDS from occurring. bit.ly/3ClLwTy
3. Quick catnaps may spark creativity. Researchers have found evidence that the brief period when drifting off to sleep may be a sweet spot for dreams that facilitate creative thinking and problem solving. bit.ly/3ChZsy8
Week of May 29, 2023:
1. NIH has launched a large precision medicine cancer initiative to test the effectiveness of new drug combinations that target specific tumor alterations. The initiative is the largest of its kind to test combinations of cancer drugs guided by tumor biology. bit.ly/3CbiDcI
2. NIH researchers discovered genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea. The study also identified a drug to target an important feedback loop that significantly improved symptoms in patients. bit.ly/3qtoyXZ
3. A case study in a brother and sister has led to the discovery of a new gene variant that affords protection against Alzheimer's disease. The Reelin pathway and brain region as promising targets for future study and development of Alzheimer’s treatments. bit.ly/3IXKjpl
Post interview, one student said: “Biosynthesis sounds insanely interesting and I did not know that Dr. Tabak was the [Acting] Director for NIH, though in my defense I only listen to that type of news occasionally because I am just a kid/preteen. It’s cool as well that I just talked to the [Acting] Director of NIH and we had a conversation!” — Haven.
Week of May 22, 2023:
1. Scientists have developed a personalized mRNA vaccine approach against a deadly type of pancreatic cancer. While still in early phases of clinical trials, half the participants in a small clinical trial had a strong anti-tumor response to the vaccine. bit.ly/3q3Cfg9
2. A large study has provided new insight into the symptoms of Long COVID. The research identified most common symptoms, potential subgroups, and an initial symptom-based scoring system. The findings aim to improve future diagnostics and treatment. bit.ly/3OHSutK
3. People with mutations that lead to excessively long chromosome tips, called telomeres, may be at increased risk for a range of cancers. While previous research suggested boosting telomere length might delay age-related illnesses, longer telomeres may carry their own set of risks. bit.ly/3Wt2GYV
4. Researchers have found that cells of glioblastoma, a fast-growing brain cancer, steal mitochondria from other cells in the nervous system, which helps the cancer cells grow. This finding could lead to new treatment options. bit.ly/3IMTEQL
5. For the first time, researchers have recorded pain-related data from inside the brain of individuals with chronic pain disorders. This finding will help researchers better understand how pain is represented by brain activity and how to modulate that activity to relieve suffering from chronic pain. bit.ly/3oGOu1P
Credit: Zvonimir Dogic, @brandeis via @NIGMS
#cilia #cells #CellsAtWork #ScienceImage #CoolScienceImage #SciArt #ScienceAnimation #science #research #BasicScience #NIH
To learn more about the research being done in Price's lab, visit irp.nih.gov/pi/sara-inati.
Interested in finding out for yourself what it's like to do research at NIH? Check out our training opportunities to learn about the IRP's programs for students, recent graduates, and postdoctoral fellows: irp.nih.gov/research-training/training-opportunities
The SciBites video shorts are produced by the @IRPatNIH. Check out their YouTube channel and visit their website at irp.nih.gov to learn more about the NIH IRP.
Week of May 15, 2023:
1. A clinical trial of an experimental universal influenza vaccine developed by NIH researchers has begun enrolling volunteers. This trial will test the experimental mRNA vaccine for safety and its ability to induce an immune response. bit.ly/3pNeitz
2. An NIH study found that new cases of chronic pain occur more often among U.S. adults than new cases of several other common conditions, including diabetes, depression, and high blood pressure. These data are the first nationwide estimates on the incidence of new chronic pain and new high impact chronic pain. bit.ly/3o5tth4
3. A first-in-human clinical trial for removing radioactive contaminants from inside the body has begun. The experimental oral drug HOPO 14-1 will be tested for safety and tolerability in healthy adults. bit.ly/3WbT3xv
4. New research shows that the economic burden of health disparities in the United States remains unacceptably high. The study revealed that in 2018, racial and ethnic health disparities cost the U.S. economy $451 billion, a 41% increase from 2014. nih.gov/news-events/news-releases/nih-funded-study-highlights-financial-toll-health-disparities-united-states
5. Vigorous exercise was found to be not linked to increased risk of death or life-threatening arrhythmia for people with hypertrophic cardiomyopathy (HCM), a rare heart condition. This research could lead to less restrictions on physical activity for those with HCM. nih.gov/news-events/news-releases/vigorous-exercise-not-tied-increased-risk-adverse-events-rare-heart-condition
Week of May 8, 2023:
1. NIH researchers identify large genetic changes that contribute to dementia risk. bit.ly/3O0lnAZ
2. Scientists release a new human “pangenome” reference. bit.ly/3o00nzF
3. Researchers develop model for how the brain acquires essential omega-3 fatty acids. bit.ly/3I1B8E4
4. Obstructive sleep apnea associated with increased risks for long COVID. bit.ly/3Blxr8h
Visit heal.nih.gov/headliners to register for upcoming webinars in this series.
Week of May 1, 2023:
1. NIH researchers uncovered new details about a rare immune deficiency which leaves people vulnerable to infectious disease, autoimmune disease, and cancer. People with the most severe cases of the disease, called idiopathic CD4 lymphocytopenia (ICL), were observed to be most at risk for developing several associated diseases. bit.ly/427qvaH
2. Researchers found that opioid-exposed newborns cared for with the “Eat, Sleep, Console” (ESC) approach had reduced hospital stays and reduced need for medication. ESC encourages parental involvement, swaddling, breastfeeding, skin-to-skin contact, and a low stimulation environment. bit.ly/3B1AnXD
3. A new study shows how socioeconomic disparities in a child's brain development can be mitigated through state anti-poverty programs. States that provide strong social safety nets had lower disparities in brain development and mental health in children aged 9 to 11. bit.ly/42c6HTI
4. Women aged 55 and younger have almost double the risk of rehospitalization in the year after having a heart attack than men of a similar age. The findings suggest a need for closer health monitoring for women aged 18 - 55 who have had heart attacks. bit.ly/44vGd0T
5. Researchers found young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia. The study highlights the need to screen for, prevent, and treat cannabis use disorder among young people. bit.ly/42wrn8H
As part of its efforts to find scientific solutions to the opioid crisis, the NIH HEAL Initiative® investigates ways to improve care of infants with NOWS. This research shows that a care approach called “Eat, Sleep, Console” (ESC) can help these infants get better with less need for opioid medications and go home from the hospital sooner.
Hear from the researchers on how ESC improves care and why it matters in helping to address the national opioid crisis. For more information, visit heal.nih.gov/ESC
Week of April 24, 2023:
1. An NIDDK supported study found people who experienced acute kidney injury (AKI) during a hospitalization were more likely to revisit the hospital or die shortly after discharge, compared to those without AKI. The findings highlight the need for further research to develop and test interventions designed to reduce the risks associated with AKI. bit.ly/40NBwMR
2. Children with multisystem inflammatory syndrome (MIS-C), a rare condition linked to COVID-19, have biomarkers indicating damage to multiple organs, the lining of blood vessels and the nervous system. The biomarkers are distinct from other children with COVID-19. These findings could lead to the development of tests allowing clinicians to differentiate between MIS-C and other conditions involving widespread inflammation. bit.ly/3NnEDrI
3. Researchers identified distinct features of the immune system of extremely long-lived people, finding centenarians develop faster, more effective immune responses to infections. The results suggest specific immune adaptations that may contribute to centenarians’ extreme longevity. bit.ly/3Li0xKi
To learn more about the research being done in Sreya's lab, visit irp.nih.gov/pi/thomas-bugge.
Interested in finding out for yourself what it's like to do research at NIH? Check out our training opportunities to learn about the IRP's programs for students, recent graduates, and postdoctoral fellows: irp.nih.gov/research-training/training-opportunities
The SciBites video shorts are produced by the @IRPatNIH. Check out their YouTube channel and visit their website at irp.nih.gov to learn more about the NIH IRP.
Week of April 17, 2023:
1. New NIAID research finds a majority of parents of children diagnosed with Lyme disease reported that their kids recovered within six months of completing antibiotic treatment. The study also found that a notably small percentage of children took longer than six months to recover and experienced a significant impact on their daily functioning. bit.ly/41RBNiT
2. The Department of Veterans Affairs and NIH have launched a study to gain a better understanding, identify biomarkers, and potential treatments of the chronic symptoms of Gulf War Illness. Symptoms of the disease impact multiple systems of the body and affects about a third of the nearly 700,000 men and women who served in the Persian Gulf during operations Desert Shield and Desert Storm. bit.ly/3L1UNUS
3. Researchers have identified a strong association between prevalence of prescription stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and rates of prescription stimulant misuse by middle and high school students. The research highlights the need to prevent medication-sharing among teens. bit.ly/41uFX02
Week of April 10, 2023:
1. Researchers developed a protein delivery system that can be customized to target specific human cell types. The system could be adapted to deliver gene therapies or cancer therapies safely and efficiently into targeted cells. bit.ly/3MFtbrf
2. An NIH clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. bit.ly/43x04fG
3. NIH’s National Cancer Institute helped launch a phase 3 randomized clinical trial of a two-drug combination to treat patients with advanced non-small cell lung cancer. The Pragmatica-Lung study is one of the first NCI-supported clinical trials to use a trial design that removes many of the barriers that prevent people from joining clinical trials. bit.ly/3UAlmEY
4. Tranexamic acid, a medication that slows the breakdown of blood clots, appears no more effective than placebo in reducing the need for blood transfusion or preventing maternal death in patients with increased risk for excessive bleeding because of cesarean delivery, according to an NIH-funded study. Tranexamic acid slows the natural breakdown of blood clots and was considered promising for reducing the risk of excessive bleeding after cesarean delivery. bit.ly/41qgPY3


